INVESTOR ALERT: Kirby McInerney LLP Notifies Investors That

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2022
62
INVESTOR ALERT: Kirby McInerney LLP Notifies Investors That It has Filed a Class Action Lawsuit Against Alteryx, Inc. with an Expanded Class Period and of the Approaching Lead Plaintiff Deadline

NEW YORK, Oct. 02, 2020 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the Central District of California, captioned Lagudi v. Alteryx, Inc., et al. (Case No. 8:20-cv-01910), on behalf of those who acquired Alteryx, Inc. (“Alteryx” or the “Company”) (NYSE: AYX ) from May 6, 2020 through August 7, 2020, inclusive (the “Class Period”). Investors have until October 19, 2020 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

The Complaint filed in this class action alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects. Specifically, Defendants failed to disclose to investors: (1) that the Company was unable to close large deals within the quarter and deals were pushed out to subsequent quarters or downsized; (2) that, as a result, Alteryx increasingly relied on adoption licenses to attract new customers; (3) that, as a result and due to the nature of adoption licenses, the Company’s revenue was reasonably likely to decline; and (4) that, as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

On August 6, 2020, after the market closed, Alteryx announced its second quarter 2020 financial results, and stated that the Company expected only 10% to 11% revenue growth for the full year, and 7% to 11% revenue growth for the third quarter of 2020 (as compared to the same period in 2019). On this news, Alteryx’s stock price fell $47.62, or more than 28%, to close at $121.38 per share on August 7, 2020.

On August 7, 2020, after the market closed, the Company filed its Quarterly Report on Form 10-Q for the period ended June 30, 2020. Therein, Alteryx further disclosed, in relevant part, that: “During the three and six months ended June 30, 2020, we continued to experience significant changes in customer buying behavior that began in March as a result of the impact of the COVID-19 pandemic, including decreased customer engagement and delayed sales cycles. As a result of these changes, we experienced a decrease in revenue from the three months ended June 30, 2020 as compared to the three months ended March 31, 2020 and deterioration in near-term demand, and saw key business metrics, including our dollar-based net expansion rate, decrease quarter over quarter… Further, as a result of the impact of the COVID-19 pandemic on our operating results for the three months ended June 30, 2020, we expect our business in fiscal 2020 to continue to perform at levels lower than planned prior to the COVID-19 pandemic.” On this news, Alteryx’s stock price fell $12.15, or 10%, to close at $109.23 per share on August 10, 2020.

If you acquired Alteryx securities, have information, or would like to learn more about these claims, please contact Thomas W. Elrod of Kirby McInerney at 212-371-6600, by email at investigations@kmllp.com , or by filling out this contact form , to discuss your rights or interests with respect to these matters without any cost to you.

Kirby McInerney is a New York-based plaintiffs’ law firm concentrating in securities, antitrust, and whistleblower litigation. The firm’s efforts on behalf of shareholders in securities litigation have resulted in recoveries totaling billions of dollars. Additional information about the firm can be found at Kirby McInerney’s website: www.kmllp.com .

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contacts

Kirby McInerney LLP Thomas W. Elrod, Esq., (212) 371-6600 investigations@kmllp.com www.kmllp.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

PathoSearch: A New Era in Pathology With Visual Search

Updated Category News Views 9

Revolutionizing Pathology with a Visual Search Engine In an era where time is money and precision is paramount, Aignostics is betting big on transforming the pathology landscape. Today, their announcement of PathoSearch, a visual search engine designed for retrieving comparable diagnosed pathology cases, marks a massive leap towards streamlining the diagnostic process....

Continue Reading
D-Wave Faces Legal Questions After CFO Exit and Losses

Updated Category News Views 2

Trouble Brews at D-Wave Quantum Smack in the middle of market chaos, D-Wave Quantum Inc. (NASDAQ: QBTS) seems to have hit a rather gnarly pothole. With disappointing revenue figures for Q2 of 2026—coming in at a measly $3.08 million, far below the expected range of $4.03 million to $4.08 million—investors have more than enough reasons to be irked. When the numbers...

Continue Reading
Damp or Dry: The Battle for Healthy Air in Colorado

Updated Category News Views 4

The Hidden Cost of Colorado's Dry Air Dry climate isn't just a seasonal inconvenience—it's a real hidden cost to living comfortably and healthily in Colorado. With winters colder than a brass monkey's tail and summers that don't offer much relief in terms of humidity, your home's air quality is on the front line. So, what's the financial tale here, and how do you come...

Continue Reading
Countries Eye New Investment Paths at CIFIT 2026

Updated Category News Views 4

Global Investment Winds Shift at CIFIT In the thick of a world that's being turned on its head, you've got big shots from 129 countries and 30 international organizations talking shop at the 26th China International Fair for Investment and Trade (CIFIT) in Xiamen. Take your pick from the 48 of the world's top 50 GDP powerhouses rubbing shoulders there—this ain't your...

Continue Reading
Protecting Teeth: Insights from Endodontist Dr. Joubert

Updated Category News Views 6

Preserving Our Natural Chompers Digging into the details of endodontic care, you realize how it's the unsung hero in the dental world. And let's face it, teeth don't get happier on their own when there's a problem on the inside. Dr. Christopher Joubert, a wiz on the endodontic front, spills the beans over at HelloNation about how essential these practices are in keeping...

Continue Reading
Ajman Spotlights Tourism at Arabian Travel Market 2026

Updated Category News Views 3

Ajman: A Tourism Gem in the Making Swinging into the Arabian Travel Market 2026, Ajman isn't just a footnote in the UAE's tourism playbook anymore, it's gunning for the spotlight. There's a flurry of activity as the Ajman Department of Tourism, Culture and Media rolls up its sleeves to flaunt the emirate's kaleidoscope of attractions to the world's tourism brass. Going...

Continue Reading
USPS Honors 150 Years of the U.S. Coast Guard Academy

Updated Category News Views 7

Honoring Tradition and Service The good ol’ U.S. Postal Service is at it again, giving a tip of the hat to a slice of American military heritage. This time, they’re putting out a new stamp to celebrate the 150th anniversary of the U.S. Coast Guard Academy. And you know where they did the honors? Right there on Custom House Pier in New London, Connecticut, a place that...

Continue Reading
Larry Ellison's Moves Signal Confidence in Oracle's Future

Updated Category News Views 6

Unraveling Ellison's Bold Decision There's nothing like a sudden shift from a tech titan to make Wall Street sit up and take notice. Today, we got the word that Larry Ellison, Oracle's big gun as Executive Chair and CTO, has pulled the plug on his plan to sell Oracle stock. No dice, no distance covered under that plan. And he's made it crystal clear—selling isn't on his...

Continue Reading
SMPL Faces Legal Drama: What Investors Need to Know

Updated Category News Views 5

Investors Swim Against the Current With SMPL Picture this: You’re sipping your morning coffee, glancing through stocks, only to choke on your bagel when The Simply Good Foods Company (NASDAQ: SMPL) pops up with some less-than-palatable news. A class action is brewing, shouting out to investors who took the bait from October 24, 2024, to April 8, 2026. If you’re one of...

Continue Reading
PureHealth's Acid Reflux Solutions: An Investor's Insight

Updated Category News Views 2

Digestive Wellness: The Emerging Opportunity Some days, it feels like everybody's got a gripe about their gut. You nod along at the lunch counter, folks buzzing about digestive this and acid that. But when PureHealth Research pops up with their fancy supplements, well, even the stock market's noisier nonsense starts sounding a bit quieter. They're banking big on the...

Continue Reading

Top 5 Most Recently Viewed Articles

Revitalizing the Gastroparesis Market with Transformative Therapies

Updated Category News Views 191

Growth Trajectory of the Gastroparesis Market The gastroparesis market is experiencing significant growth, projected to achieve a remarkable CAGR of 21.9% by 2034. This surge is mainly due to the introduction of innovative therapeutic classes that offer the promise of improved efficacy and reduced side effects. Novel agents like the Dopamine D2 receptor antagonist have...

Continue Reading
Innovative Trends in the Aviation Actuator Market Outlook

Updated Category News Views 192

Growth and Transformation of the Aviation Actuator System Market The aviation actuator system market is on a robust growth trajectory, currently valued at approximately US$ 1.7 billion in recent years. Forecasts predict a steady rise, with expectations to reach a remarkable market value of US$ 3.1 billion by the end of the forecast period. This growth is largely...

Continue Reading
Pulsenmore Partners with Prominent U.S. Medical Center for Ultrasound Innovation

Updated Category News Views 131

Pulsenmore Partners with a Leading Medical Center in the U.S. Pulsenmore Ltd. (NASDAQ: PLSM), a trailblazer in home ultrasound technology, has marked a significant milestone in its journey by engaging in its first commercial partnership with a renowned medical center in the United States. This initiative comes on the heels of receiving FDA approval for their cutting-edge...

Continue Reading
Meta Platforms Set to Reveal Year-End 2025 Financials

Updated Category News Views 245

Meta Platforms Gearing Up for Year-End Financial Results Meta Platforms, Inc. (NASDAQ: META) has announced that its financial results for the fourth quarter and full year 2025 will be disclosed after the market closes. This much-anticipated release is scheduled for January 28, 2026. Financial analysts and investors alike are eager to assess Meta's performance as the...

Continue Reading
Jacobs Strengthens Ireland's Railway Infrastructure Through Expansion

Updated Category News Views 184

Jacobs to Support Ireland's Railway Infrastructure Transformation Jacobs is stepping into an essential role as a multi-disciplinary consultant, aiding in the modernization and expansion of Ireland's railway infrastructure. This initiative is focused on improving regional accessibility and the crucial corridors that interconnect cities, laying the groundwork for expanded...

Continue Reading